国际口腔医学杂志 ›› 2019, Vol. 46 ›› Issue (3): 263-269.doi: 10.7518/gjkq.2019034
Xinyuan Zhang,Bin Wang,Hui Yu,Liwen Zhu,Lin Xiang()
摘要:
在哺乳动物中,Hippo信号通路具有高度保守性,其在调节骨代谢、维持骨骼正常生理功能方面有重要作用。哺乳动物sterile 20样激酶(MST)1/2、大肿瘤抑制因子(LATS)1/2和Yes相关蛋白(YAP)/携带PDZ结合基序的转录辅助激活物(TAZ)为Hippo信号通路核心组件,在其上下游多种转录因子的介导下,Hippo信号通路调控成骨细胞、破骨细胞、软骨细胞等细胞的生理活动。本文就Hippo信号通路在骨代谢中的研究进展进行综述,为骨代谢相关疾病的研究和治疗提供可能的思路和策略。
中图分类号:
[1] |
Harvey KF, Pfleger CM, Hariharan IK . The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis[J]. Cell, 2003,114(4):457-467.
doi: 10.1016/S0092-8674(03)00557-9 pmid: 12941274 |
[2] |
Justice RW, Zilian O, Woods DF , et al. The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation[J]. Genes Dev, 1995,9(5):534-546.
doi: 10.1101/gad.9.5.534 pmid: 7698644 |
[3] |
Johnson R, Halder G . The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment[J]. Nat Rev Drug Discov, 2014,13(1):63-79.
doi: 10.1038/nrd4161 pmid: 4167640 |
[4] |
Yu FX, Zhao B, Guan KL . Hippo pathway in organ size control, tissue homeostasis, and cancer[J]. Cell, 2015,163(4):811-828.
doi: 10.1016/j.cell.2015.10.044 pmid: 4638384 |
[5] |
Wang J, Martin JF . Hippo pathway: an emerging regulator of craniofacial and dental development[J]. J Dent Res, 2017,96(11):1229-1237.
doi: 10.1177/0022034517719886 pmid: 28700256 |
[6] |
Okamoto K, Nakashima T, Shinohara M , et al. Osteoimmunology: the conceptual framework unifying the immune and skeletal systems[J]. Physiol Rev, 2017,97(4):1295-1349.
doi: 10.1152/physrev.00036.2016 pmid: 28814613 |
[7] |
Scheel H, Hofmann K . A novel interaction motif, SARAH, connects three classes of tumor suppressor[J]. Curr Biol, 2003,13(23):R899-R900.
doi: 10.1016/j.cub.2003.11.007 |
[8] |
Gladden AB, Hebert AM, Schneeberger EE , et al. The NF2 tumor suppressor, Merlin, regulates epidermal development through the establishment of a junctional polarity complex[J]. Dev Cell, 2010,19(5):727-739.
doi: 10.1016/j.devcel.2010.10.008 pmid: 21074722 |
[9] |
Das Thakur M, Feng Y, Jagannathan R , et al. Ajuba LIM proteins are negative regulators of the Hippo signaling pathway[J]. Curr Biol, 2010,20(7):657-662.
doi: 10.1016/j.cub.2010.02.035 pmid: 20303269 |
[10] |
Hansen CG, Moroishi T, Guan KL . YAP and TAZ: a nexus for Hippo signaling and beyond[J]. Trends Cell Biol, 2015,25(9):499-513.
doi: 10.1016/j.tcb.2015.05.002 pmid: 26045258 |
[11] |
Lee J, Youn BU, Kim K , et al. Mst2 controls bone homeostasis by regulating osteoclast and osteoblast differentiation[J]. J Bone Miner Res, 2015,30(9):1597-1607.
doi: 10.1002/jbmr.2503 pmid: 257616702 |
[12] |
Oh S, Lee D, Kim T , et al. Crucial role for Mst1 and Mst2 kinases in early embryonic development of the mouse[J]. Mol Cell Biol, 2009,29(23):6309-6320.
doi: 10.1128/MCB.00551-09 |
[13] |
Katagiri K, Imamura M, Kinashi T . Spatiotemporal regulation of the kinase Mst1 by binding protein RAPL is critical for lymphocyte polarity and adhesion[J]. Nat Immunol, 2006,7(9):919-928.
doi: 10.1016/S0020-0190(99)00120-9 pmid: 16892067 |
[14] |
Zhou D, Medoff BD, Chen L , et al. The Nore1B/Mst1 complex restrains antigen receptor-induced proliferation of naïve T cells[J]. Proc Natl Acad Sci USA, 2008,105(51):20321-20326.
doi: 10.1073/pnas.0810773105 pmid: 19073936 |
[15] |
Mou F, Praskova M, Xia F , et al. The Mst1 and Mst2 kinases control activation of rho family GTPases and thymic egress of mature thymocytes[J]. J Exp Med, 2012,209(4):741-759.
doi: 10.1084/jem.20111692 pmid: 22412158 |
[16] |
Salojin KV, Hamman BD, Chang WC , et al. Genetic deletion of Mst1 alters T cell function and protects against autoimmunity[J]. PLoS One, 2014,9(5):e98151.
doi: 10.1371/journal.pone.0098151 |
[17] |
Varelas X . The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease[J]. Development, 2014,141(8):1614-1626.
doi: 10.1242/dev.102376 pmid: 24715453 |
[18] |
Zhu Y, Wu Y, Cheng J , et al. Pharmacological activation of TAZ enhances osteogenic differentiation and bone formation of adipose-derived stem cells[J]. Stem Cell Res, Ther, 2018,9(1):53.
doi: 10.1186/s13287-018-0799-z pmid: 29514703 |
[19] |
Pan H, Xie Y, Zhang Z , et al. YAP-mediated mechanotransduction regulates osteogenic and adipogenic differentiation of BMSCs on hierarchical structure[J]. Colloids Surf B Biointerfaces, 2017,152:344-353.
doi: 10.1016/j.colsurfb.2017.01.039 pmid: 28131959 |
[20] |
王飞, 张慧宇, 窦予昕 , 等. 降钙素基因相关肽通过Hippo通路调控小鼠骨髓间充质干细胞成骨分化的实验研究[J]. 华西口腔医学杂志, 2016,34(3):286-290.
doi: 10.7518/hxkq.2016.03.014 |
Wang F, Zhang HY, Dou YX , et al. Calcitonin gene-related peptide-induced osteogenic differentiation of mouse bone marrow stromal cells through Hippo pathway in vitro[J]. West Chin J Stomatol, 2016,34(3):286-290.
doi: 10.7518/hxkq.2016.03.014 |
|
[21] |
Levaot N, Simoncic PD, Dimitriou ID , et al. 3BP2-deficient mice are osteoporotic with impaired osteoblast and osteoclast functions[J]. J Clin Invest, 2011,121(8):3244-3257.
doi: 10.1172/JCI45843 pmid: 3148735 |
[22] |
Matsumoto Y, La Rose J, Kent OA , et al. Reciprocal stabilization of ABL and TAZ regulates osteoblastogenesis through transcription factor RUNX2[J]. J Clin Invest, 2016,126(12):4482-4496.
doi: 10.1172/JCI87802 pmid: 27797343 |
[23] |
Kegelman CD, Mason DE, Dawahare JH , et al. Skeletal cell YAP and TAZ combinatorially promote bone development[J]. FASEB J, 2018,32(5):2706-2721.
doi: 10.1096/fj.201700872R pmid: 29401582 |
[24] |
Xiong J, Almeida M , O’Brien CA. The YAP/TAZ transcriptional co-activators have opposing effects at different stages of osteoblast differentiation[J]. Bone, 2018,112:1-9.
doi: 10.1016/j.bone.2018.04.001 pmid: 29626544 |
[25] |
Jiang J, Chang W, Fu Y , et al. SAV1 represses the development of human colorectal cancer by regulating the Akt-mTOR pathway in a YAP-dependent manner[J]. Cell Prolif, 2017,50(4). doi: 10.1111/cpr. 12351.
doi: 10.1111/cpr.12351 pmid: 28618450 |
[26] |
Zhao L, Guan H, Song C , et al. YAP1 is essential for osteoclastogenesis through a TEADs-dependent mechanism[J]. Bone, 2018,110:177-186.
doi: 10.1016/j.bone.2018.01.035 pmid: 29432919 |
[27] |
Nagase Y, Iwasawa M, Akiyama T , et al. Anti-apoptotic molecule Bcl-2 regulates the differentiation, activation, and survival of both osteoblasts and osteoclasts[J]. J Biol Chem, 2009,284(52):36659-36669.
doi: 10.1074/jbc.M109.016915 pmid: 19846553 |
[28] |
Li W, Dong S, Wei W , et al. The role of transcriptional coactivator TAZ in gliomas[J]. Oncotarget, 2016,7(50):82686-82699.
doi: 10.18632/oncotarget.12625 pmid: 27764783 |
[29] |
Karystinou A, Roelofs AJ, Neve A , et al. Yes-associated protein (YAP) is a negative regulator of chondrogenesis in mesenchymal stem cells[J]. Arthritis Res Ther, 2015,17:147.
doi: 10.1186/s13075-015-0639-9 pmid: 4449558 |
[30] |
Deng Y, Wu A, Li P , et al. Yap1 regulates multiple steps of chondrocyte differentiation during skeletal development and bone repair[J]. Cell Rep, 2016,14(9):2224-2237.
doi: 10.1016/j.celrep.2016.02.021 pmid: 26923596 |
[31] |
Yang B, Sun H, Song F , et al. YAP1 negatively regulates chondrocyte differentiation partly by activating the β-catenin signaling pathway[J]. Int J Biochem Cell Biol, 2017,87:104-113.
doi: 10.1016/j.biocel.2017.04.007 pmid: 28438716 |
[32] |
Li C, Wang S, Xing Z , et al. A ROR1-HER3-lncRNA signalling axis modulates the Hippo-YAP pathway to regulate bone metastasis[J]. Nat Cell Biol, 2017,19(2):106-119.
doi: 10.1038/ncb3464 pmid: 5336186 |
[33] |
Aoyama E, Kubota S, Khattab HM , et al. CCN2 enhances RANKL-induced osteoclast differentiation via direct binding to RANK and OPG[J]. Bone, 2015,73:242-248.
doi: 10.1016/j.bone.2014.12.058 pmid: 255545972 |
[34] |
Nishida T, Emura K, Kubota S , et al. CCN family 2/connective tissue growth factor (CCN2/CTGF) promotes osteoclastogenesis via induction of and interaction with dendritic cell-specific transmembrane protein (DC-STAMP)[J]. J Bone Miner Res, 2011,26(2):351-363.
doi: 10.1002/jbmr.222 pmid: 20721934 |
[35] |
Del Re DP, Matsuda T, Zhai P , et al. Proapoptotic Rassf1A/Mst1 signaling in cardiac fibroblasts is protective against pressure overload in mice[J]. J Clin Invest, 2010,120(10):3555-3567.
doi: 10.1172/JCI43569 pmid: 2947240 |
[36] |
Lock FE, Underhill-Day N, Dunwell T , et al. The RASSF8 candidate tumor suppressor inhibits cell growth and regulates the Wnt and NF-kappaB signaling pathways[J]. Oncogene, 2010,29(30):4307-4316.
doi: 10.1038/onc.2010.192 pmid: 20514026 |
[37] |
Song H, Kim H, Lee K , et al. Ablation of Rassf2 induces bone defects and subsequent haematopoietic anomalies in mice[J]. EMBO J, 2012,31(5):1147-1159.
doi: 10.1038/emboj.2011.480 pmid: 22227519 |
[38] |
Guo W, Keckesova Z, Donaher JL , et al. Slug and Sox9 cooperatively determine the mammary stem cell state[J]. Cell, 2012,148(5):1015-1028.
doi: 10.1016/j.cell.2012.02.008 pmid: 3305806 |
[39] |
Lin Y, Li XY, Willis AL , et al. Snail1-dependent control of embryonic stem cell pluripotency and lineage commitment[J]. Nat Commun, 2014,5:3070.
doi: 10.1038/ncomms4070 pmid: 24401905 |
[40] |
Tang Y, Weiss SJ . Snail/Slug-YAP/TAZ complexes cooperatively regulate mesenchymal stem cell function and bone formation[J]. Cell Cycle, 2017,16(5):399-405.
doi: 10.1080/15384101.2017.1280643 pmid: 28112996 |
[41] |
Tang Y, Feinberg T, Keller ET , et al. Snail/Slug binding interactions with YAP/TAZ control skeletal stem cell self-renewal and differentiation[J]. Nat Cell Biol, 2016,18(9):917-929.
doi: 10.1038/ncb3394 pmid: 27479603 |
[42] |
Jang EJ, Jeong H, Kang JO , et al. TM-25659 enhances osteogenic differentiation and suppresses adipogenic differentiation by modulating the transcriptional co-activator TAZ[J]. Br J Pharmacol, 2012,165(5):1584-1594.
doi: 10.1111/j.1476-5381.2011.01664.x pmid: 21913895 |
[43] |
Lin Z, Fateh A, Salem DM , et al. Periosteum: biology and applications in craniofacial bone regeneration[J]. J Dent Res, 2014,93(2):109-116.
doi: 10.1177/0022034513506445 |
[44] |
Wang C, Inzana JA, Mirando AJ , et al. NOTCH signaling in skeletal progenitors is critical for fracture re- pair[J]. J Clin Invest, 2016,126(4):1471-1481.
doi: 10.1172/JCI80672 pmid: 26950423 |
[45] |
Manderfield LJ, Aghajanian H, Engleka KA , et al. Hippo signaling is required for Notch-dependent smooth muscle differentiation of neural crest[J]. Development, 2015,142(17):2962-2971.
doi: 10.1242/dev.125807 pmid: 26253400 |
[46] |
Zanconato F, Forcato M, Battilana G , et al. Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth[J]. Nat Cell Biol, 2015,17(9):1218-1227.
doi: 10.1038/ncb3216 pmid: 26258633 |
[47] |
You B, Yang YL, Xu Z , et al. Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells[J]. Oncotarget, 2015,6(6):4357-4368.
doi: 10.18632/oncotarget.2974 pmid: 4414195 |
[48] |
Wang DY, Wu YN, Huang JQ , et al. Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance[J]. Chin J Cancer, 2016,35:47.
doi: 10.1186/s40880-016-0109-z pmid: 4875723 |
[49] |
朱忠胜, 张春林, 汪泱 . Hippo信号通路作用分子TAZ在人骨肉瘤及骨肉瘤干细胞中的表达[J]. 中国骨与关节杂志, 2014,3(2):130-134.
doi: 10.3969/j.issn.2095-252X.2014.02.012 |
Zhu ZS, Zhang CL, Wang Y . Expressions of effective molecules transcriptional coactivator with plasma dissociated zircon-binding motif of Hippo signaling pathway in human osteosarcomas and osteosarcoma stem cells[J]. Chin J Bone Tumor Bone Dis, 2014,3(2):130-134.
doi: 10.3969/j.issn.2095-252X.2014.02.012 |
[1] | 朱轩智,赵蕾. 甲状腺功能减退症与牙周炎相关性的研究进展[J]. 国际口腔医学杂志, 2021, 48(4): 380-384. |
[2] | 孙坚炜,雷利红,谭静怡,陈莉丽. 微小RNA 155对骨免疫的调控及其在牙周炎中作用的研究进展[J]. 国际口腔医学杂志, 2020, 47(5): 607-615. |
[3] | 吴琪, 刘程程, 郑黎薇, 李继遥, 周学东, 徐欣. 肠道微生物调控骨代谢的研究进展[J]. 国际口腔医学杂志, 2017, 44(6): 628-635. |
[4] | 伍颖颖,宫苹. 胰岛素对糖尿病大鼠种植体周骨组织代谢影响的研究[J]. 国际口腔医学杂志, 2017, 44(2): 183-188. |
[5] | 胥欣 王艳民 白丁. 沉默交配型信息调节因子2同源蛋白1与骨和软骨代谢的关系[J]. 国际口腔医学杂志, 2016, 43(5): 569-572. |
[6] | 郝旭蕾 梁新华. HIPPO通路在口腔系统发育和疾病中的研究进展[J]. 国际口腔医学杂志, 2016, 43(1): 52-. |
[7] | 於丽明1 沈庆平1 陈锦坤2. 脂联蛋白及其与成骨和骨代谢的关系[J]. 国际口腔医学杂志, 2015, 42(6): 681-684. |
[8] | 邹华伟,张士文,袁泉. 慢性肾脏病对牙周组织的影响[J]. 国际口腔医学杂志, 2014, 41(6): 730-734. |
[9] | 陈明月1,2 汪昌宁1. 过氧化物酶增生物激活受体γ及其分子作用机制与牙周炎[J]. 国际口腔医学杂志, 2014, 41(5): 598-602. |
[10] | 吕琳琳 李纾. Yes相关蛋白基因在牙发育中的作用[J]. 国际口腔医学杂志, 2013, 40(6): 760-763. |
[11] | 王蕊综述 吴哲审校. 辛伐他汀在骨代谢中作用的研究进展[J]. 国际口腔医学杂志, 2011, 38(3): 335-338. |
[12] | 马婷综述 张健审校. 唑来膦酸局部给药影响骨代谢在口腔医学中的应用[J]. 国际口腔医学杂志, 2011, 38(3): 349-353. |
|